the present invention relates to novel peptides that are highly biologically and pharmacologically active as therapeutic agents for the treatment of numerous lung diseases or lung and / or bronchi related diseases , especially chronic obstructive pulmonary disease , cystic fibrosis , and bronchiolitis obliterans . the synthetic peptides according to the invention are derivatives of vasoactive intestinal peptide and show enhanced physical , pharmacological and biological / therapeutic properties compared to vip .